Obaid-Ur-Rahman Abid et al. / Tetrahedron Letters 51 (2010) 657–660
659
3 was isolated as viscous colourless oil (3.65 g, 87%). 1H NMR (300 MHz,
CDCl3): d = 3.86 (s, 3 H, OCH3), 3.88 (s, 3H, OCH3), 7.92 (s, 1H, ArH). 13C NMR
In conclusion, we reported a convenient approach to dimethyl
4-chloro-3,5-dihydroxyphthalate by [4+2] cycloaddition of 1-eth-
oxy-2-chloro-1,3-bis(trimethyl-silyloxy)-1,3-diene with dimethyl
acetylenedicarboxylate (DMAD). The Suzuki–Miyaura coupling of
the bis(triflate) of the product proceeds with very good site-selec-
tivity and provides a convenient approach to 3,5-diaryl-4-chlor-
ophthalates containing two different aryl groups. The preparative
scope of the methodology is currently being studied.
1
(62.90 MHz, CDCl3): d = 52.6 (OCH3), 52.7 (OCH3), 117.5 (q, JCF = 321 Hz, CF3),
1
117.6 (q, JCF = 321 Hz, CF3), 123.0 (CH), 126.5, 128.7, 130.0, 142.4. 145.8 (C),
167.7 (2C, C@O). 19F NMR (282.4 MHz. CDCl3): d = À71.99 (CF3), À73.20 (CF3).
IR (ATR, cmÀ1): v = 3103 (w), 2960 (w), 2850 (w), 2054 (w), 1980 (w), 1739 (s),
1599 (w), 1567 (w), 1429 (s), 1395 (m), 1305 (m), 1277 (m), 1206 (s), 1129 (s),
1113 (s), 1005 (s), 961 (s), 919 (w), 859 (w), 820 (m), 787 (s), 751 (s), 732 (s),
698 (m), 651 (m), 593 (s), 574 (m). MS (EI, 70 eV): m/z (%): 524 (M+, 30), 493
(100), 460 (13), 429 (39), 391 (4), 365 (36), 299 (42), 271 (6), 238 (11), 199
(12), 171 (9), 143 (3), 84 (8), 69 (38), 59 (13). HRMS (EI) calcd for
C12H7O10ClF6S2 [M+]: 523.90679, found 523.907255.
Acknowledgements
12. General procedure for Suzuki–Miyaura reactions: A 1,4-dioxane solution (4 mL
per 0.3 mmol of 3) of 3, K3PO4, Pd(PPh3)4 and arylboronic acid 4 was stirred at
110 °C or 90 °C for 6 or 8 h. After cooling to 20 °C, a saturated aqueous solution
of NH4Cl was added. The organic and the aqueous layers were separated and
the latter was extracted with CH2Cl2. The combined organic layers were dried
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was
purified by column chromatography.
Financial support by the State of Pakistan (HEC scholarships for
O.-U.-R. A., M.F.I.), by the DAAD (scholarship for O.-U.-R. A. and
M.N.) and by the State of Mecklenburg-Vorpommern is gratefully
acknowledged.
13. Dimethyl 4-chloro-3,5-di(4-tolyl)phthalate (5f): Starting with
3
(157 mg,
4-
0.3 mmol), K3PO4 (191 mg, 0.9 mmol), Pd(PPh3)4 (3 mol %),
methylphenylboronic acid (98 mg, 0.72 mmol) and 1,4-dioxane (4 mL), 5f
was isolated as a colourless solid (88 mg, 72%); mp = 139–141 °C. 1H NMR
(300 MHz, CDCl3): d = 2.33 (s, 3H, CH3), 2.35 (s, 3H, CH3), 3.51 (s, 3H, OCH3),
3.82 (s, 3H, OCH3), 7.10–7.18 (m, 4H, ArH), 7.21–7.29 (m, 4H, ArH), 7.91 (s, 1H,
ArH). 13C NMR (62.89 MHz, CDCl3): d = 21.3 (ArCH3), 21.4 (ArCH3), 52.3 (OCH3),
52.6 (OCH3), 125.3 (C), 128.7 (2CH), 128.9 (2CH), 129.2 (2CH), 129.4 (2CH),
131.7 (CH), 133.4, 135.7, 136.1, 137.4, 138.0, 138.1, 140.0, 142.2 (C), 165.3
(CO), 168.0 (CO). IR (ATR, cmÀ1): v = 3026 (w), 2949 (w), 2922 (w), 2859 (w),
2253 (w), 1906 (w), 1727 (s), 1613 (w), 1584 (w), 1552 (w), 1514 (m), 1434
(m), 1373 (w), 1340 (m), 1259 (s), 1237 (s), 1213 (m), 1145 (m), 1104 (m), 1069
(m), 1021 (m), 969 (m), 909 (m), 890 (m), 814 (m), 783 (m), 730 (m), 720 (m),
634 (m), 554 (m). MS (EI, 70 eV): m/z (%): 411 (M+1, 37Cl, 9), 410 (M+, 37Cl, 36),
409 (M+1, 35Cl, 26), 408 (M+, 35Cl, 97), 380 (8), 379 (35), 378 (25), 377 (100),
347 (8), 345 (23), 318 (3), 290 (4), 289 (5), 255 (8), 239 (15), 226 (4), 204 (7),
178 (3), 126(9), 91 (2), 59 (1). HRMS (EI) calcd for C24H21O4Cl [M+]: 408.11229,
found 408.112793.
References and notes
1. For pharmacologically active chlorinated natural products and drugs, see: (a)
Gribble, G. W. Environ. Sci. Technol. 1994, 28, 310A; (b) Gribble, G. W. J. Chem.
Ed. 1994, 71, 907; (c) Gribble, G. W. Acc. Chem. Res. 1998, 31, 141; (d) Gribble, G.
W. Acc. Chem. 1996, 68, 1699; (e) Gribble, G. W. J. Nat. Prod. 1992, 55, 1353;
Griseofulvin (f) Osborne, C. S.; Leitner, I.; Hofbauer, B.; Fielding, C. A.; Favre, B.;
Ryder, N. S. Antimicrob. Agents Chemother. 2006, 50, 2234; (g) Takano, R.;
Sugano, K.; Higashida, A.; Hayashi, Y.; Machida, M.; Aso, Y.; Yamashita, S.
Pharm. Res. 2006, 23, 1144; (h) Xue, C.; Li, T.; Deng, Z.; Fu, H.; Lin, W. Pharmazie
2006, 61, 1041; (i) Phelps, J. B.; Hoffman, W. P.; Lee, C.; Murphy, G. P.; Garriott,
M. L. Mutat. Res. 2004, 561, 153; (j) Rosefort, C.; Fauth, E.; Zankl, H. Mutagenesis
2004, 19, 277; (k) Kinobe, R. T.; Dercho, R. A.; Vlahakis, J. Z.; Brien, J. F.; Szarek,
W. A.; Nakatsu, K. J. Pharmacol. Exp. Ther. 2006, 319, 277; (l) Albaugh, D.; Albert,
G.; Bradford, P.; Cotter, V.; Froyd, J. J. Antibiot. 1998, 51, 317; Dihydronidulin
(m) Finlay-Jones, P. F.; Sala, T.; Sargent, M. V. J. Chem. Soc., Perkin Trans. 1 1981,
874.
14. Dimethyl 4-chloro-3-(2-methoxyphenyl)-5-(trifluoromethylsulfonyl-oxy)phthalate
(6a): Starting with
Pd(PPh3)4 (3 mol %), 2-methoxyphenylboronic acid (50 mg, 0.33 mmol) and
1,4-dioxane (4 mL), 6a was isolated as colourless solid (68 mg, 47%),
3 (157 mg, 0.3 mmol), K3PO4 (95.4 mg, 0.45 mmol),
2. For an example from our laboratory, see: (a) Albrecht, U.; Lalk, M.; Langer, P.
Bioorg. Med. Chem. 2005, 13, 1531; (b) Nguyen, V. D.; Wolf, C.; Mäder, U.; Lalk,
M.; Langer, P.; Lindequist, U.; Hecker, M.; Antelmann, H. Proteomics 2007, 7,
1391.
3. Metal-Catalyzed Cross-Coupling Reactions; de Meijere, A., Diederich, F., Eds.;
Springer: Weinheim, 2004.
a
mp = 103–105 °C. 1H NMR (300 MHz, CDCl3): d = 3.70 (s, 3H, OCH3), 3.82 (s,
3H, OCH3), 3.91 (s, 3H, OCH3), 6.92 (d, J = 8.4 Hz, 1H, ArH), 6.98 (dt, J = 7.4,
1.0 Hz, 1H, ArH), 7.11 (dd, J = 7.5, 1.7 Hz, 1H, ArH), 7.37 (dt, J = 7.8, 1.7 Hz, 1H,
ArH), 7.86 (s, 1H, ArH). 13C NMR (75.46 MHz, CDCl3): d = 52.0 (OCH3), 52.3
(OCH3), 54.9 (OCH3), 110.0 (CH), 117.5 (q, J = 321 Hz, CF3), 119.5 (CH), 124.7,
127.0, 128.5, (C), 129.3, 129.8, 131.2 (CH), 131.9, 141.2, 141.3, 155.4 (C), 163.1
(CO), 163.4 (CO). 19F NMR (282.4 MHz, CDCl3): d = À71.99 (CF3). IR (ATR, cmÀ1):
v = 2955 (w), 2923 (w), 2849 (W), 1738 (s), 1730 (m), 1607 (w), 1582 (w), 1501
(w), 1468 (w), 1429 (w), 1325 (w), 1270 (s), 1242 (m), 1210 (m), 1164 (w),
1135 (m), 1112 (w), 1009 (w), 926 (w), 806 (m), 755 (m), 672 (w), 639 (w), 598
(m), 572 (w), 547 (w), 573 (w). MS (EI, 70 eV): m/z (%): 484 (M+, 37Cl, 40), 482
(M+, 35Cl, 100), 451 (25), 415 (2), 387 (4), 317 (27), 289 (20), 250 (16), 229 (5),
195 (6), 168 (6), 139 (6), 69 (9), 59 (5). HRMS (EI) calcd for C18H14O8ClF3S [M+]:
482.00445, found 482.005219.
4. Corral, C.; Lissavetzky, J.; Manzanares, I. Synthesis 1997, 29.
5. For a review of 1,3-bis(silyl enol ethers), see: Langer, P. Synthesis 2002, 441.
6. (a) Chan, T.-H.; Brownbridge, P. J. Chem. Soc., Chem. Commun. 1979, 578; (b)
Krägeloh, K.; Simchen, G. Synthesis 1981, 30.
7. For a review of [3+3] cyclizations, see: Feist, H.; Langer, P. Synthesis 2007, 327.
8. For the synthesis and reactions of a 4-chloro-1,3-bis(trimethylsilyloxy)-1,3-
butadiene, see: (a) Reim, S.; Langer, P. Tetrahedron Lett. 2008, 49, 2329; For an
isolated example of a 2-chloro-1,3-bis(trimethylsilyloxy)-1,3-butadiene, see:
(b) Savard, J.; Brassard, P. Tetrahedron Lett. 1979, 20, 4911; For [3+3]
cyclizations of 1,3-bis(silyloxy)-1,3-dienes with 2-chloro-3-silyloxy-2-en-1-
ones, see: (c) Yawer, M. A.; Hussain, I.; Reim, S.; Ahmed, Z.; Ullah, E.; Iqbal, I.;
Fischer, C.; Reinke, H.; Görls, H.; Langer, P. Tetrahedron 2007, 63, 12562; For
synthetic applications of 2-chloro-1,3-bis(silyloxy)-1,3-butadienes, see: (d)
Reim, S.; Adeel, M.; Hussain, I.; Yawer, M. A.; Villinger, A.; Langer, P.
Tetrahedron Lett. 2008, 49, 4901.
15. General procedure for the synthesis of 7a,b: The reaction was carried out in a
pressure tube. To a dioxane suspension (4 mL) of 3 (236 mg, 0.45 mmol),
Pd(PPh3)4 (3 mol %) and Ar1B(OH)2 (0.5 mmol) was added K3PO4 (143 mg,
0.67 mmol), and the resultant solution was degassed by bubbling argon
through the solution for 10 min. The mixture was heated at 90 °C under Argon
atmosphere for 8 h. The mixture was cooled to 20 °C. Ar2B(OH)2 (0.6 mmol)
and K3PO4 (143 mg, 0.67 mmol) were added. The reaction mixtures were
heated under an Argon atmosphere for 6 h at 110 °C. They were diluted with
water and extracted with CH2Cl2 (3 Â 25 mL). The combined organic layers
were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The
residue was purified by flash chromatography (silica gel, EtOAc/heptanes).
16. Dimethyl 4-chloro-3-(4-ethylphenyl)-5-(4-trifluoromethylphenyl)-phthalate (7a):
Starting with 3 (236 mg, 0.45 mmol), K3PO4 (143 mg, 0.67 mmol), Pd(PPh3)4
(3 mol %), 4-ethylphenylboronic acid (75 mg, 0.5 mmol), 1,4-dioxane (4 mL)
and 4-trifluoromethylphenylboronic acid (114 mg, 0.6 mmol), 7a was isolated
as colourless crystals (122 mg, 57%), mp = 138–140 °C. 1H NMR (300 MHz,
CDCl3): d = 1.22 (d, J = 7.8 Hz, 3H, CH3), 2.65 (q, J = 7.5 Hz, 2H, CH2), 3.48 (s, 3H,
OCH3), 3.82 (s, 3H, OCH3), 7.21–7.32 (m, 4H, ArH), 7.35–7.38 (m, 2H, ArH),
7.60–7.63 (m, 2H, ArH), 7.97 (s, 1H, ArH). 13C NMR (62.89 MHz, CDCl3): d = 15.3
(CH3), 28.6 (CH2), 52.4 (OCH3), 52.7 (OCH3), 124.0 (q, J = 272 Hz, CF3), 125.0 (q,
3JCF = 3.7 Hz, 2CH), 125.7 (C), 127.8 (2CH), 129.2 (2CH), 130.2 (2CH), 130.6 (d,
2JCF = 32.5 Hz, C), 132.4 (CH), 135.4, 135.8, 136.8, 138.5 (C), 140.0 (d, J = 1.4 Hz,
C), 142.5, 144.6 (C), 165.1, 167.6 (CO). 19F NMR (282.4 MHz, CDCl3): d = À62.7
(CF3). IR (ATR, cmÀ1): v = 3026 (w), 2949 (w), 2922 (w), 2859 (w), 2253 (w),
1906 (w), 1727 (s), 1613 (w), 1584 (w), 1552 (w), 1514 (m), 1434 (m), 1373
(w), 1340 (m), 1259 (s), 1237 (s), 1213 (m), 1145 (m), 1104 (m), 1069 (m), 1021
(m), 969 (m), 909 (m), 890 (m), 814 (m), 783 (m), 730 (m), 720 (m), 634 (m),
554 (m). MS (EI, 70 eV): m/z (%): 479 (M+1, 37Cl, 9), 478 (M+, 37Cl, 36), 477
(M+1, 35Cl, 29), 476 (M+, 35Cl, 99), 461 (30), 447 (41), 445 (100), 415 (5), 387
(4), 343 (5), 309 (7), 239 (6), 215 (8), 199 (4), 163 (1), 151 (3), 119 (4), 59 (2), 29
(1). HRMS (ESI) calcd for C25H20O4ClF3 [M]+: 476.1002, calcd for [M+H]+:
9. For a review of site-selective palladium(0)-catalyzed cross-coupling reactions
of polyhalogenated substrates, see: Schröter, S.; Stock, C.; Bach, T. Tetrahedron
2005, 61, 2245.
10. Dimethyl 4-chloro-3,5-dihydroxyphthalate (2): Diene 1 (463 mg, 1.5 mmol) was
added to DMAD (319 mg, 0.27 mL, 2.25 mmol) at À78 °C. The mixture (neat)
was allowed to warm to 20 °C for 20 h with stirring. To the mixture was added
hydrochloric acid (10%) and dichloromethane (30 mL each). The organic and
the aqueous layers were separated and the latter was extracted with CH2Cl2.
The combined organic layers were dried (Na2SO4), filtered and the filtrate was
concentrated in vacuo. The residue was purified by column chromatography to
give 2 as a crystalline colourless solid (195 mg, 50%), mp = 127–129 °C. 1H NMR
(250 MHz, CDCl3): d = 3.82 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 6.57 (s, 1H, OH),
6.57 (s, 1H, ArH), 11.55 (s, 1H, OH). 13C NMR (62.90 MHz, CDCl3): d = 52.8
(OCH3), 53.0 (OCH3), 103.5 (C), 107.5 (CH), 109.3, 135.0 (C), 156.6, 158.7 (C–
OH), 168.6, 169.0 (C@O). IR (ATR, cmÀ1): v = 2984 (w), 2954 (w), 2905 (w),
2847 (w), 1792 (w), 1722 (s), 1668 (m), 1435 (m), 1328 (m), 1243 (s), 1067 (s),
844 (m). MS (EI, 70 eV): m/z (%): 262 (M+, 37Cl, 9), 260 (M+, 35Cl, 15), 228 (53),
198 (23), 170 (100), 153 (23), 89 (25). Anal. Calcd for C10H9ClO6: C 46.08, H
3.48. Found: C 46.21, H 3.31.
11. Dimethyl 4-chloro-3,5-bis(trifluoromethylsufonyloxy)phthalate (3): To a solution
of 2 (1.0 equiv) in CH2Cl2 (10 mL/mmol) was added pyridine (4.0 equiv) at
À78 °C under an argon atmosphere. After 10 min, Tf2O (2.4 equiv) was added at
À78 °C. The mixture was allowed to warm up to 0 °C and stirred for 4 h. The
reaction mixture was filtered and the filtrate was concentrated in vacuo. The
products of the reaction mixture were isolated by rapid column
chromatography (flash silica gel, heptanes/EtOAc). Starting with 2 (2.080 g,
8.0 mmol), pyridine (2.6 mL, 32.0 mmol), CH2Cl2 and Tf2O (3.2 mL, 19.2 mmol),